Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 47: 730-738, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petibois, C.
Right arrow Articles by Déléris, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petibois, C.
Right arrow Articles by Déléris, G.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2001;47:730-738.)
© 2001 American Association for Clinical Chemistry, Inc.


Articles

Plasma Protein Contents Determined by Fourier-Transform Infrared Spectrometry

Cyril Petibois1,2, Georges Cazorla2, André Cassaigne3 and Gérard Déléris1,a

1 INSERM U443, Equipe de Chimie Bio-Organique,
2 Faculté des Sciences du Sport et de l’Education Physique, and
3 Département de Biochimie Médicale et Biologie Moléculaire, Laboratoire de Biochimie, CHU Bordeaux, Université Victor Segalen Bordeaux 2, 146 rue Léo Saignat, 33076 Bordeaux, France.
a Author for correspondence. Fax 33-5-5757-1002; e-mail gerard.deleris{at}bioorga.u-bordeaux2.fr.

Background: Fourier-transform infrared (FT-IR) spectrometry has been used to measure small molecules in plasma. We wished to extend this use to measurement of plasma proteins.

Methods: We analyzed plasma proteins, glucose, lactate, and urea in 49 blood samples from 35 healthy subjects and 14 patients. For determining the concentration of each biomolecule, the method used the following steps: (a) The biomolecule was sought for which the correlation between spectral range areas of plasma FT-IR spectra and concentrations determined by comparison method was greatest. (b) The IR absorption of the biomolecule at the most characteristic spectral range was calculated by analyzing pure samples of known concentrations. (c) The plasma concentration of the biomolecule was determined using the FT-IR absorption of the pure compound and the integration value obtained for the plasma FT-IR spectra. (d) The spectral contribution of the biomolecule was subtracted from the plasma FT-IR spectra, and the resulting spectra were saved for further analyses. (e) The same method was then applied to determining the concentrations of other biomolecules by sequentially comparing the resulting FT-IR spectra.

Results: Results agreed with those obtained by clinical methods for the following biomolecules when analyzed in the following order: albumin, glucose, fibrinogen, IgG2, lactate, IgG1, {alpha}1-antitrypsin, {alpha}2-macroglobulin, transferrin, apolipoprotein (Apo)-A1, urea, Apo-B, IgM, Apo-C3, IgA, IgG4, IgG3, IgD, haptoglobin, and {alpha}1-acid glycoprotein.

Conclusion: FT-IR spectrometry is a useful tool for determining concentrations of several plasma biomolecules.




The following articles in journals at HighWire Press have cited this article:


Home page
J. Clin. Endocrinol. Metab.Home page
C. Petibois, A. Cassaigne, H. Gin, and G. Deleris
Lipid Profile Disorders Induced by Long-Term Cessation of Physical Activity in Previously Highly Endurance-Trained Subjects
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3377 - 3384.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.